105.80
0.36%
0.375
Schlusskurs vom Vortag:
$105.42
Offen:
$106.16
24-Stunden-Volumen:
85,636
Relative Volume:
0.75
Marktkapitalisierung:
$2.36B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
87.44
EPS:
1.21
Netto-Cashflow:
$33.49M
1W Leistung:
+2.28%
1M Leistung:
+23.54%
6M Leistung:
+32.66%
1J Leistung:
+98.31%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
105.80 | 2.36B | 213.03M | 41.32M | 33.49M | 1.21 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
2024-08-02 | Fortgesetzt | Lake Street | Buy |
2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
2024-04-26 | Hochstufung | Stifel | Hold → Buy |
2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2021-09-16 | Eingeleitet | Jefferies | Buy |
2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
2019-07-25 | Bestätigt | Barrington Research | Outperform |
2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
2018-04-26 | Herabstufung | Stifel | Buy → Hold |
2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
2016-07-28 | Bestätigt | Barrington Research | Outperform |
2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Witnessing An Insider Decision, George LeMaitre Exercises Options Valued At $187K At LeMaitre Vascular - Benzinga
LeMaitre To Participate At Upcoming Investor Conferences In December - Barchart
LeMaitre to Participate at Upcoming Investor Conferences in December - GlobeNewswire
Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today? - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Lowered to Hold Rating by StockNews.com - Defense World
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Price Boost Is Out Of Tune With Earnings - Simply Wall St
When the Price of (LMAT) Talks, People Listen - Stock Traders Daily
Victory Capital Management Inc. Acquires 10,011 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Insider Selling: Lawrence Jasinski Sells Shares of LeMaitre Vasc - GuruFocus.com
LeMaitre Vascular stock soars to all-time high of $106.78 By Investing.com - Investing.com South Africa
LeMaitre Vascular stock soars to all-time high of $106.78 - Investing.com India
Bridget Ross At LeMaitre Vascular Decides to Exercises Options Worth $276K - Benzinga
Oppenheimer Asset Management Inc. Cuts Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Ex-Dividend Reminder: LeMaitre Vascular, Discover Financial Services and Bgc Group - Nasdaq
Atria Investments Inc Acquires 2,701 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular director Shadan Martha sells $151,547 in stock - Investing.com
(LMAT) Technical Data - Stock Traders Daily
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Raised by Los Angeles Capital Management LLC - MarketBeat
LMATLeMaitre Vascular, Inc. Latest Stock News & Market Updates - StockTitan
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year HighShould You Buy? - MarketBeat
Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular stock soars to all-time high of $104.33 By Investing.com - Investing.com Australia
Portside Wealth Group LLC Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular stock soars to all-time high of $104.33 - Investing.com India
500: Something went wrong - Investing.com
LeMaitre Vascular Inc (LMAT) Quarterly 10-Q Report - Quartzy
LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com India
(01/18/21) Top Picks 2021: Avid Technology (AVID) and LeMaitre Vascular (LM - Moneyshow.com
Harbor Capital Advisors Inc. Buys 12,797 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
FY2024 EPS Forecast for LeMaitre Vascular Lifted by Analyst - MarketBeat
LeMaitre Vascular: Market Catching On To Dividend Growth Story (NASDAQ:LMAT) - Seeking Alpha
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16 - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by F M Investments LLC - MarketBeat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High Following Earnings Beat - Defense World
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Receives "Outperform" Rating from Oppenheimer - MarketBeat
Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion - Investing.com
LeMaitre Vascular Inc (LMAT) Trading 12.71% Higher on Nov 1 - GuruFocus.com
Barrington Research Raises LeMaitre Vascular (NASDAQ:LMAT) Price Target to $93.00 - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular - Benzinga
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Sets New 52-Week High After Strong Earnings - MarketBeat
LeMaitre Vascular stock target upgraded, keeps buy rating on strong Q3 results - Investing.com UK
Conestoga Capital Advisors LLC Purchases 36,850 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):